Skip to main content

LH

Stock
Health Care
Diagnostics & Research

Performance overview

LH Price
Price Chart

Forward-looking statistics

Beta
0.36
Risk
20.18%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Company info

SectorHealth Care
IndustryDiagnostics & Research
Employees46K
Market cap$16.6B

Fundamentals

Enterprise value$28.2B
Revenue$13.2B
Revenue per employee—
Profit margin5.55%
Debt to equity79.13

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$8.67
Dividend per share$2.88
Revenue per share$157.30
Avg trading volume (30 day)$179M
Avg trading volume (10 day)$197M
Put-call ratio—

Macro factor sensitivity

Growth+1.5
Credit+2.3
Liquidity-0.9
Inflation-0.3
Commodities+0.4
Interest Rates-1.7

Valuation

Dividend yield1.10%
PEG Ratio16.35
Price to sales1.66
P/E Ratio16.35
Enterprise Value to Revenue2.14
Price to book2.64

Upcoming events

Next earnings dayApril 29, 2025
Next dividend day—
Ex. dividend dayMay 29, 2025

News

How Will Celsius Leverage Its Energy Drink Market Share in 2025?

CELH rides rising lifestyle trends with bold innovations, shelf gains and the Alani Nu boost driving energy market share.

Zacks Investment Research (July 21, 2025)
Gear Up for L3Harris (LHX) Q2 Earnings: Wall Street Estimates for Key Metrics

Evaluate the expected performance of L3Harris (LHX) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks Investment Research (July 21, 2025)
Labcorp Q2 Earnings Preview: Diagnostics Strength in Focus

LH is likely to report Q2 growth with diagnostics momentum, key acquisitions, and new biomarker tests bolstering revenue gains.

Zacks Investment Research (July 21, 2025)
Why Norwegian Cruise Line (NCLH) Dipped More Than Broader Market Today

In the latest trading session, Norwegian Cruise Line (NCLH) closed at $22.74, marking a -2.28% move from the previous day.

Zacks Investment Research (July 15, 2025)
Here's Why L3Harris Stock Looks Promising for Your Portfolio Now

LHX's global defense reach, acquisitions and rising earnings outlook make it a strong pick in the aerospace defense industry.

Zacks Investment Research (July 11, 2025)
Buy 3 High-Flying Drone Technology Stocks to Enhance Your Returns

JBL, HEI, and LHX have each surged over 17% in three months, fueled by strong drone tech momentum and rising defense demand.

Zacks Investment Research (July 11, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free